'short-term' (< 24 h; range, 3-24 h) and 'prolonged' (> 24 h; range, 1-10 (median crosssectional area, 18.1 (IQR,

Objective To assess long-term outcomes of children who had ovarian cysts diagnosed prenatally. MethodsWe reviewed prenatal records of fetuses diagnosed with ovarian cysts in our ultrasound unit children were invited to our institute for transabdominal pelvic sonographic re-examination. Demonstration of the uterus and adnexa was required.Results Twenty-one children were diagnosed prenatally with either simple (n = 11) or complex (n = 12) ovarian cysts and treated by either conservative management (n = 13) or surgical intervention (n = 10) postnatally. The ipsilateral ovary was not detected in 8 of 11 children in whom a complex cyst had been detected on the first postnatal scan. Significantly higher rate of ovarian loss was diagnosed when the sonographic appearance of the ovarian cyst was simple on the prenatal scan and complex on the postnatal scan (six of seven) compared with when the ovarian cyst was simple on both scans (one of four, P = 0.04). ConclusionPrenatal detection of complex ovarian cyst might indicate close monitoring in order to alert the need for early intervention for preventing impending ovarian loss. Further researches are needed to empower this study.

Introduction: Skin biopsies can be used to evaluate physiological effects of aging targeted intervention at the tissue/cellular levels. Recent clinical trials have shown that hyperbaric oxygen therapy (HBOT) can target aging hallmarks, including telomere shortening, senescent cells clearance and angiogenesis. The aim of this study was to evaluate the effects of HBOT on the skin of a normal, non-pathological, aging population. Methods: The study was performed as a prospective clinical trial. After signing informed consent and undergoing baseline evaluations, the subjects were assigned to a three-month control period followed by three months of HBOT daily sessions. Skin biopsies were taken at baseline, after three months of no intervention (control) and 1-2 weeks following the last HBOT session. Trichrome, Orecin, lipofuscin and CD31 staining were used to evaluate collagen fibers, elastic fibers, senescent cells and blood vessels, respectively. Results: Out of the cohort of 70 participants in the normal aging population study, thirteen male patients (age 68.07±2.5y) gave consent for repeated skin biopsies. Following HBOT, there was a significant increase in collagen density (p<0.001, effect size(es)=1.10), elastic fiber length (p<0.0001, es=2.71) and the number of blood vessels (p=0.02, es=1.00). There was a significant decrease in fiber fragmentation (p=0.012) and in tissue senescent cells (p=0.03, es=0.84) post-HBOT. No changes were noted in elastic fiber density or thickness. Conclusions: The study indicates, for the first time in humans, that HBOT can significantly modulate the pathophysiology of the skin aging in a healthy aging population. The demonstrated mechanisms include angiogenesis and senescent cell clearance.